Skip to main content
BMC Microbiology logoLink to BMC Microbiology
. 2009 Mar 30;9:62. doi: 10.1186/1471-2180-9-62

Diarrhoeagenic Escherichia coli are not a significant cause of diarrhoea in hospitalised children in Kuwait

M John Albert 1,, Vincent O Rotimi 1, Rita Dhar 2, Susan Silpikurian 1, Alexander S Pacsa 1, A Majid Molla 3, Gyorgy Szucs 1
PMCID: PMC2678128  PMID: 19331674

Abstract

Background

The importance of diarrhoeagenic Escherichia coli (DEC) infections in the Arabian Gulf including Kuwait is not known. The prevalence of DEC (enterotoxigenic [ETEC], enteropathogenic [EPEC], enteroinvasive [EIEC], enterohemorrhagic [EHEC] and enteroaggregative [EAEC]) was studied in 537 children ≤ 5 years old hospitalised with acute diarrhoea and 113 matched controls from two hospitals during 2005–07 by PCR assays using E. coli colony pools.

Results

The prevalence of DEC varied from 0.75% for EHEC to 8.4% for EPEC (mostly atypical variety) in diarrhoeal children with no significant differences compared to that in control children (P values 0.15 to 1.00). Twenty-seven EPEC isolates studied mostly belonged to non-traditional serotypes and possessed β and θ intimin subtypes. A total of 54 DEC isolates from diarrhoeal children and 4 from controls studied for antimicrobial susceptibility showed resistance for older antimicrobials, ampicillin (0 to 100%), tetracycline (33 to 100%) and trimethoprim (22.2 to 100%); 43.1% of the isolates were multidrug-resistant (resistant to 3 or more agents). Six (10.4%) DEC isolates produced extended spectrum β-lactamases and possessed genetic elements (blaCTX-M, blaTEM and ISEcp1) associated with them.

Conclusion

We speculate that the lack of significant association of DEC with diarrhoea in children in Kuwait compared to countries surrounding the Arabian Gulf Region may be attributable to high environmental and food hygiene due to high disposable income in Kuwait.

Background

Diarrhoeal diseases are a major childhood health problem. Although children in developing countries are the worst affected, children from more developed countries also suffer from diarrhoeal diseases, albeit to a lesser extent. Kuwait is a relatively small country of approximately 17,820 km2situated in the desert Arabian Gulf region [1]. It has a population of approximately three million people of which two-thirds are expatriates working for the oil-rich economy [1]. Kuwait is considered a developing country with a high per capita income [2]. The country has a protected piped water supply system. Almost all of the food items are imported from different parts of the world which are routinely screened for microbial safety by the State Public Health Laboratory. Diarrhoeal diseases are a part of the disease spectrum in this country as in other countries. The last study on diarrhoeal diseases in hospitalised children in Kuwait was conducted in early 1980s [3]. That time, not all categories of diarrhoeagenic Escherichia coli (DEC) were known. Of late, at least six categories of DEC are known to contribute to disease in different parts of the world. These include enterotoxigenic E. coli (ETEC), enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), enterohaemorrhagic E. coli (EHEC), enteroaggregative E. coli (EAEC) and diffusively adherent E. coli (DAEC)[4]. However, Koch's postulates have been fulfilled for five categories excluding DAEC [5]. Therefore, we investigated the aetiology of the five categories of DEC in hospitalised children with diarrhoea in Kuwait to assess their importance in this part of the world. DEC isolates were further characterised for their antimicrobial susceptibility and extended spectrum β-lactamase (ESBL) production. In addition, the EPEC isolates were characterised for their serotypes and intimin subtypes [6].

Methods

Subjects

The subjects included 537 consecutive children hospitalised with acute diarrhoea (defined as three or more loose stools during a 24 h period with duration of diarrhoea ≤ 14 days) and 113 control children without diarrhoea. The diarrhoeal children were hospitalised because of dehydration. The children were up to five years of age and were recruited from Al-Adan Hospital (AH) or Al-Farwaniya Hospital (FH), Kuwait, during August 2005 to March 2007. Control children were admitted for non-gastrointestinal illnesses, but were matched for corresponding age of the diarrhoeal children. The children had not taken antibiotics prior to hospital admission and there was no follow-up of them after stool sample collection. Informed oral consent was given by the parents or guardians of children for the study as per local institutional guidelines.

Stool samples

A fresh stool specimen was collected from children with diarrhoea, and from control children without diarrhoea, as soon as after admission. It was promptly sent to the Microbiology Laboratory of each hospital where it was cultured on MacConkey agar (Oxoid, Basingstoke, UK). The plate was incubated at 37°C for 24 h. The next day, the MacConkey plate (Oxoid) and the stool specimen were sent in a refrigerated box to Department of Microbiology, Faculty of Medicine, Kuwait University.

Detection of DEC

Entire E. coli growth from MacConkey plate (including both lactose fermenting and non-lactose fermenting colonies) was transferred to Luria broth (Becton Dickinson, Franklin Lakes, NJ, USA) containing 30% (vol/vol) glycerol, which was then frozen at -70°C until studied for detection of ETEC, EPEC, EIEC, EHEC and EAEC by PCR assays as described by Robins-Browne et al [7]. For detection of these DEC, a loopful of the frozen culture was grown in 2.5 ml of MacConkey broth (Oxoid) in a shaker incubator at 37°C overnight. The pelleted bacterial growth was washed in 1 ml of phosphate buffered saline (PBS)(pH, 7.2), resuspended in 200 μl sterile distilled water, and boiled for 10 min. After cooling on ice, bacteria were pelleted by centrifugation and supernatant stored for ≤ 1 week at -20°C before use. PCR reaction was carried out in a total volume of 25 μl using 5 μl of thawed supernatant diluted 1: 5 in PBS (pH, 7.2) as the template in all PCR reactions. Initially, the presence of E. coli was checked by PCR reaction for lacZ gene [7]. If positive, then PCR assays for DEC were carried out. The primers and the PCR conditions corresponded to lac Z gene [7], eltA and estA genes (for ETEC), bfpA and eaeA genes (for EPEC), stx1and stx2 genes (for EHEC), and AggA gene (for EAEC) [7] and ipH gene (for EIEC) [8]. The PCR buffer contained 10 mM Tris-HCl (pH 8.3), 25 mM MgCl2, 10 mM each of dnTP, and 1 unit of Taq Gold polymerase (Amplitaq gold, Applied Biosystems, Branchburg, NJ, USA) and 6.5 pmol each of the primer. The reaction volume was made up to 25 μl with distilled water. The following E. coli control strains were used in PCR reactions: EPEC strain, 2348/69; EHEC strain, EDL 933; ETEC strain, H10407; EIEC strain, 223–83; and EAEC strain, O42 (provided by Professor R. Robins-Browne, University of Melbourne, Parklville, Victoria, Australia). Amplified DNA fragments were resolved by gel electrophoresis with 2% (wt/vol) agarose. The gels were stained with ethidium bromide (0.5 μg/ml) and bands visualised with UV illumination.

Isolation of DEC from mixed E. coli growth

Frozen E. coli growth from individuals positive for DEC were replated on MacConkey agar (Oxoid) for isolated colonies and up to 10 individual colonies were tested for the DEC initially identified in the pooled growth. Growth from single colonies identified as DEC was stored frozen at -70°C for further studies on intimin subtyping (EPEC isolates only) and antimicrobial susceptibility (all DEC isolates) (see below).

Subtyping of the eae gene

The subtyping of intimin from EPEC strains into 14 subtypes was carried out as described by Ramachandran et al [6]. A single forward primer (EaeVF) and three reverse primers (EaeVR, EaeZeataVR and EaeIotaVR) were used to amplify a 834- to-876-bp fragment representing the 3' variable regions of the reported intimin variants. The composition of the PCR buffer was as above, but 50 pmol of each primer was used. The template (5 μl) used was the same as above for identification of EPEC. The reaction volume was made up to 50 μl with distilled water. After amplification, the DNA products were resolved by agarose gel electrophoresis as described above. The PCR products generated with the cocktails of the four primers were incubated separately with 3 U of each of the restriction enzymes AluI, RsaI, and CfoI (New England Biolabs, Ipswich, MA, USA) for 4 h at 37°C. The digested fragments were separated by agarose gel electrophoresis and visualised by ethidium bromide staining. Intimin subtypes were identified by comparing the generated profiles with those reported previously [6]. Any profile that did not fit with the published profiles was considered to be of indeterminate type [6].

Serotyping of EPEC strains

Selected EPEC isolates from diarrhoeal children and control children were serotyped at the Health Protection Agency's Laboratory of Enteric Pathogens, Colindale, England, the United Kingdom, by tube agglutination method [9].

Antibiotic susceptibility testing of DEC

DEC strains were tested for susceptibility to a number of antimicrobial agents by E test (AB Biodisk, Solna, Sweden). Bacterial suspension in Mueller-Hinton broth (Difco, Becton Dickinson, NJ, USA) equivalent to 0.5 McFarland optical density was used to inoculate Mueller-Hinton agar. E test antimicrobial strips were placed on the plate, which was then incubated at 37°C for 20 h. The MIC value was read where the growth inhibition ellipse intersected the antibiotic gradient concentration. The susceptibility test was controlled by the quality control organism, Escherichia coli ATCC 25922. The test bacteria were categorised as susceptible or resistant as per published criteria [10].

Detection of genes mediating ESBL production

All DEC strains were screened for ESBL production by the Etest ESBL method using both ceftazidime/ceftazidime combined with clavulanic acid and cefotaxime/cefotaxime combined with clavulanic acid acid strips (AB Biodisk) as described previously [11]. The three common β-lactamase-encoding genes, blaTEM, blaSHV and blaCTX-Mand the insertion sequence mobilizing the blaCTX-M gene, ISEcp1 were detected by PCR assays as described previously [11]. The expected amplicon sizes were 971 bp (blaTEM), 798 bp (blaSHV), 543 bp (blaCTX-M) and 527 bp (ISEcp). The PCR products of blaCTX-M and ISEcp genes were sequenced and compared with the sequences in the public data bank by BLAST (Basic Local Alignment Search Tool) algorithm to determine their types.

Statistics

The significance of the difference in the prevalence of pathogens between patients and controls was calculated by Chi square test. A P value ≤ 0.05 was considered significant.

Results

The age stratification of children with diarrhoea and control children from AH and FH is shown in Table 1. The majority of the patients and controls were ≤ 2 years of age. The detection of DEC from case-control study of children in AH and FH is shown in Table 2. A total of 85 (15.8%) diarrhoeal children harboured a DEC. Among these 85 children were 2 children with dual infections: 1 had an EPEC and EAEC and the other ETEC and EIEC. The prevalence was greatest for EPEC among patients. Comparison of prevalence of EPEC between patients and controls did not show statistically significant difference. Of the 45 patients positive for EPEC, 21(6.01%) were up to two years of age. Of the 8 control children positive for EPEC, 7 (7.95%) were up to two years of age. There was no significant difference in the prevalence of EPEC between patients and controls up to 2 years of age (P = 0.68). Only 2 patients harboured typical EPEC (positive for both attaching and effacing gene and bundle-forming pilus gene). The other 43 patients and all 8 controls positive for EPEC harboured atypical EPEC isolates (positive for attaching and effacing gene only). The other categories of DEC were present in a small number of patients and not in controls.

Table 1.

Age strata of 537 diarrhoeal children and 113 control children from Al-Adan and Al-Farwaniya hospitals, Kuwait

Age (months) strata Number of diarrhoeal children Number of control children
0–12 250 69
13–24 99 19
25–36 88 8
37–48 60 8
49–60 40 9

Table 2.

Detection of diarrhoeagenic E. coli from 537 diarrhoeal children and 113 control children from Al-Adan and Al-Farwaniya hospitals, Kuwait

No (%) of infected children P value

Organism Diarrhoeal Control
ETECa 10 (1.86) 0 (0.00) 0.22
EPECb 45 (8.38) 8 (7.08) 0.85
EIECc 12 (2.24) 0 (0.00) 0.24
EHECd 4 (0.75) 0 (0.00) 1.00
EAECe 14 (2.61) 0 (0.00) 0.15

aEnterotoxigenic E. coli bEnteropathogenic E. coli

cEnteroinvasive E. coli d Enterohaemorrhagic E. coli

eEnteroaggregative E. coli

The children with EIEC or EHEC infection did not have bloody diarrhea.

Entire E. coli growth from a total of 45 diarrhoeal children and 8 control children was positive for EPEC. On further testing of individual colonies, EPEC colonies could be recovered from 33 diarrhoeal children and 4 control children. Of the 10 diarrhoeal children from both hospitals initially positive for ETEC, ETEC colonies were recovered from 9 children. Of the 12 diarrhoeal children initially positive for EIEC, EIEC colonies could be recovered from 3 children. Of the 14 diarrhoeal children initially positive for EAEC, EAEC colonies could be recovered from 9 children. None of the 4 children initially positive for EHEC yielded EHEC colonies.

The isolated colonies from the above 54 diarrhoeal children and 4 control children were tested for their susceptibilities to 12 antimicrobial agents. The results are summarised in Table 3. There was no resistance to amikacin and imipenem. Resistance to aztreonam, cefotaxime, chloramphenicol, ciprofloxacin, gentamicin and ticarcillin/clavulanic acid was rare. Resistance was significant to ampicillin, tetracycline and trimethoprim. Detailed analysis showed that 16 DEC isolates were susceptible to all antimicrobial agents; six isolates (9.7%) were resistant to 1 agent, 11 isolates (17.7%) were resistant to 2 agents and 25 isolates (43.1%) were resistant to 3 or more agents; and two EPEC isolates, one ETEC isolate and one EAEC isolates were resistant to 7 antimicrobial agents each.

Table 3.

Antimicrobial susceptibility of diarrhoeagenic E. coli isolated from patients and controls from Al-Adan and Al-Farwaniya hospitals, Kuwait

Organism (n)/antibiotic MIC (μg/ml) % Resistant

Range MIC50 MIC90
EPEC a(37)
Amikacin 0.75 – 3 1.5 1.5 0
Ampicillin 3.0 – >256 4 >256 45.9
Ampicillin/sulbactam 0.023 – 64 3 16 29.7
Aztreonam 0.023 – 24 0.047 0.094 5.4
Cefotaxime 0.047 – >256 0.064 0.094 5.4
Chloramphenicol 0.032 – >256 4 8 8.1
Ciprofloxacin 0.006 – 0.25 0.008 0.125 0
Gentamicin 0.004 – 64 0.38 1 8.1
Imipenem 0.094 – 0.25 0.19 0.19 0
Tetracycline 0.5 – 192 1.5 96 40.5
Tircacillin/clavulanic acid 0.75 – 24 2 12 5.41
Trimethoprim 0.19 – >32 1 >32 43.2
ETEC b(9)
Amikacin 1 – 8 2 2 0
Ampicillin 2 – >256 >256 >256 66.7
Ampicillin/sulbactam 1.5 – 24 4 24 33.3
Aztreonam 0.023 – 32 0.032 0.047 11.1
Cefotaxime 0.047 – >256 0.064 3 11.1
Chloramphenicol 2 – 8 4 8 0
Ciprofloxacin 0.004 – >32 0.012 0.032 11.1
Gentamicin 0.25 – 128 1.5 2 11.1
Imipenem 0.094 – 0.75 0.19 0.5 0
Tetracycline 1 – 96 1.5 96 33.3
Tircacillin/clavulanic acid 1.5 – 12 2 8 0
Trimethoprim 0.19 – >32 0.38 >32 22.2
EAEC c (9)
Amikacin 1 – 4 2 2 0
Ampicillin >256 – >256 >256 >256 100
Ampicillin/sulbactam 4 – 16 12 16 55.6
Aztreonam 0.016 – 32 0.094 12 33.3
Cefotaxime 0.032 – >256 0.19 >256 44.4
Chloramphenicol 3 – >256 4 8 11.1
Ciprofloxacin 0.004 – 4 0.008 0.19 11.1
Gentamicin 0.38 – 48 1 32 22.2
Imipenem 0.094 – 0.19 0.19 0.19 0
Tetracycline 1.5 – >256 96 192 88.9
Tircacillin/clavulanic acid 1 – 24 12 12 11.1
Trimethoprim 0.38 – >32 >32 >32 77.8
EIEC d(3)
Amikacin 1.5 – 2 1.5 2 0
Ampicillin 1.5 – 4 3 4 0
Ampicillin/sulbactam 1 – 2 1.5 2 0
Aztreonam 0.032 – 0.064 0.047 0.064 0
Cefotaxime 0.032 – 0.047 0.047 0.047 0
Chloramphenicol 3 – 4 4 4 0
Ciprofloxacin 0.004 – 0.125 0.094 0.125 0
Gentamicin 0.19 – 0.75 0.5 0.75 0
Imipenem 0.19 – 0.19 0.19 0.19 0
Tetracycline 32 – 96 96 96 100
Tircarcillin/clavulanic acid 0.38 – 1.5 1.5 1.5 0
Trimethoprim >32 – >32 >32 >32 100

aEnteropathogenic E. coli bEnterotoxigenic E. coli cEnteroaggregative E. coli dEnteroinvasive E. coli

Six of the above 58 DEC strains (10.4%) produced ESBL and all of them were isolated from patients with diarrhoea with none from control children. All six strains were resistant to cefotaxime. The types of related genetic elements carried by these strains are shown in Table 4. The strains belonged to EPEC (atypical), EAEC and ETEC categories of DEC. All strains were positive for blaCTX-M and none carried blaSHV. Some strains were positive for blaTEM or ISEcp1.

Table 4.

Extended spectrum β-lactamase (ESBL)-related genes carried by ESBL-positive strains of diarrhoeagenic E. coli (DEC).

Positive for gene

Strain no. Category blaCTX-Md blaSHV blaTEM ISEcp1
62 EAECa 14-b - + +
269 EAEC 28 - - -
270 EAEC 28 - - -
306 EAEC 28 - - +
318 ETECb 28 - + +
454 EPECc 28 - + +

aEnteroaggregative E. coli bEnterotoxigenic E. coli

cEnteropathogenic E. coli

d Type of blaCTX-M indicated

EPEC colonies recovered from 24 diarrhoeal children and 3 control children were serotyped. (EPEC isolates from 9 diarrhoeal children and 1 control child were accidentally lost while cleaning a freezer). Their intimin subtypes were also determined. The results are presented in Table 5. There were 8 intimin subtypes and many belonged to β, followed by θ. Intimin from one isolate could not be amplified with the four primers used for subtyping. Isolates from 7 children only belonged to the traditional EPEC serotypes (indicated in bold types) [12].

Table 5.

Serotypes and intimin subtypes of EPEC isolated from children with diarrhoea and control children in Kuwait

Strain number Serotype Intimin subtype Strain number Serotype Intimin subtype
23 O121:H19 Int-ε 222 O111ac:HNT Int-ν
24 O118: H8 Int-θ 224 OE8686–77:H21 Int-β
49 O129:H19 Int-ε
87 ONT: HNTa Int-ξ 229 O111ac:H- Int-β
89 O113:H19 Int-ν 231 ONT:HNT Int-θ
121 ONT: H2 Int-ε 246 O26:H- Int-β
127 O55:H-b Int-θ 251 O26:H- Int-θ
130 O157:H- Int-κ 252 O26:H- Int-β
151 O123:HNT Int-ε 257 O85:H31 Int-ζ
153 ONT: H- Int-θ 319 O98:H- Int-ζ
159 O145:HNT Int-α1 341 O85:H31 Int-ζ
174 O85:H- Int-ζ C34d ONT:HNT Int-θ
197 O80:H- NTc C90d ONT:H7 Int-β
213 O118:H11 Int-β C87d O26:H- Int-β

a OHT:HNT = O & H antigens non-typeable

bSerotypes in bold-face are traditional EPEC serotypes

cNT = Intimin non-typeable

dIsolates from control children; all other isolates were from children with diarrhoea

Discussion

All five categories of DEC were present in Kuwaiti children with diarrhoea. The prevalence was greatest for EPEC. However, comparison of its prevalence with control children did not show any significant association of EPEC with diarrhoea. It is believed that EPEC would be associated with diarrhoea in children up to two years of age only [13]. Comparison of prevalence of EPEC in children up to two years of age also did not show significant difference between patients and controls. Other categories of DEC were present only in a small number of patients; none of the controls harboured these organisms. E. coli colony pools from some children were initially positive for a DEC. But a DEC could not be detected on subsequent testing of individual colonies. It is likely that DEC were present in very small numbers in these cases that were not detected on screening of individual colonies. Thus, PCR screening of entire bacterial growth from a plate is superior to other methods of detection of pathogens when the pathogens are swamped by normal flora.

Thus, this case-control study suggested that DEC are not epidemiologically associated with Kuwaiti children hospitalised for diarrhoea. Nevertheless, these organisms could still cause diarrhoea in some individual patients. In the previous study conducted in children in Kuwait, the prevalence of ETEC was 9% and EPEC 7% [3]. Compared to that study, the prevalence of ETEC was lower and that of EPEC was similar in the current study. In studies of childhood diarrhoea from the surrounding region, varying prevalence for DEC was observed. In children in Egypt, ETEC contributed to a heavy burden of diarrhoea accounting for 1.5 episodes per child per year [14]. In a study conducted in Tehran, Iran [15], the prevalence of different categories of DEC varied from 7.3% to 44.5% in diarrhoeal cases. In a case-control study of diarrhoea in Tunisian children [16], both cases and controls had a high prevalence of DEC (up to 37%) making an association with diarrhoea difficult. In Bedouin infants in Southern Israel, the prevalence of various categories of DEC varied from 0.2% to 25.9%, but ETEC was the only pathotype significantly associated with diarrhoea [17].

EPEC are classified into two types. Type I or typical EPEC are positive for both eae gene and bfp gene and mostly belong to the traditional serotypes. Type II or atypical EPEC are positive for eae gene only and belong to non-traditional serotypes [18]. In several recent studies [7,19-24], the prevalence of atypical EPEC seems to be on the rise. It is now considered to be an emerging pathogen. In some studies, atypical EPEC was found to be associated with persistent diarrhoea [19,24,25]. Similarly, in our study too, most of the EPEC were of atypical variety and were of non-traditional serotypes. A future study in Kuwait should address whether atypical EPEC are associated with persistent diarrhoea.

The majority of children in our study had nonbloody diarrhoea. Even those children who had EIEC or EHEC detected in their stools, did not present with bloody diarrhoea. It has been reported that in some cases, these infections do not result in bloody diarrhoea [26].

Intimin is the outer membrane protein of EPEC that mediates tight attachment between the bacterium and the intestinal mucosa. We investigated the intimin subtypes of EPEC. There were eight subtypes and the most prevalent subtypes were β and θ. These were also the most frequently identified subtypes in other studies [6,7,24].

Antimicrobial susceptibility studies of DEC showed that resistance to older antimicrobials such as ampicillin, tetracycline and trimethoprim was appreciable and that multi-resistance (resistance to ≥ 3 antimicrobials) was present in 43.1% of the isolates. The resistance rates of DEC to different antimicrobial agents have varied in different studies. In the study in Tehran, Iran, a high prevalence of resistance to above three antimicrobial agents as in Kuwait was observed [15]. In the study in Tunis, Tunisia, a high prevalence of resistance to tetracycline and β-lactams was seen [16]. In ETEC isolates studied in Egypt, a high prevalence of resistance to ampicillin, trimethoprim and tetracycline was seen; 28% of isolates showed multi-resistance; and resistance to other antimicrobials was rare [27]. In Mexico, resistance rates to ampicillin, tetracycline and trimethoprim were high and multi-resistance was 62%; there was no resistance to ciprofloxacin and cefotaxime [28]. In Vietnam, resistance rates to ampicillin, trimethoprim and chloramphenicol exceeded 75% with 90% of all strains multi-resistant. Resistance to ciprofloxacin and imipenem was negligible [29]. A total of six E. coli isolates were resistant to a third-generation cephalosporin, cefotaxime. All of them were ESBL producers and possessed one or more genetic elements related to ESBL production. Five isolates had ISEcp1 element that is responsible for mobilization of bla genes [30]. There are very few reports of ESBL production by DEC [31-33]. DEC isolates in these studies were found to harbor blaCTX-M [31-33], blaTEM [32,33] or blaPER genes [33]. In Kuwait, children with invasive diarrhea are normally treated with third generation cephalosporins. It is interesting that some of our DEC isolates were resistant to cefotaxime. Therefore, the prevalence of resistance to third generation cephalosporins should be continuously monitored to detect any increase in resistance rate that could affect treatment with this class of antibiotics.

Our study has shown that all five categories of DEC reported from other parts of the world were also present in diarrhoeal children in Kuwait. However, the prevalence of four DEC categories (ETEC, EHEC, EIEC and EAEC) was very low. Even though EPEC was present in about 8% of children with diarrhoea, its prevalence in control children was similar. Thus, the overall burden of diarrhoeal disease due to DEC in Kuwaiti children appeared to be low. This is in contrast to the high burden of diseases due to DEC in countries surrounding the Arabian Gulf Region. We speculate that a number of factors might influence this low prevalence in Kuwait. These include a protected water supply, an arid climate, inspection of imported food items to prevent contaminated food items reaching the population, and better housing, sanitation and nutrition of population because of high disposable income.

There are some limitations in our study. We have studied only severe cases of diarrhoea that required hospitalisation. Therefore, the role of diarrhoeagenic E. coli in mild diarrhoeas could not be ascertained. Ideally, we should have studied equal numbers of cases and matched controls. We were able to recruit only a small number of control children because we found it difficult to persuade guardians of children to allow us to collect stool samples from children. Even with a comparatively small number of control children, we could not find a statistical association of DEC with diarrhea as many of these control children excreted DEC. Therefore, even with a larger sample size of control children, the conclusion would have been the same. In most of the diarrhoeal children, other pathogens would have been the cause of diarrhoea. Traditional bacterial and parasitic diarrhoeal pathogens are investigated by routine diagnostic laboratories in the two hospitals on a need basis, but not systematically. Our interest was to evaluate the aetiolo gical role of DEC only. Had we found a significant role for DEC, this would have necessitated ruling out the contribution of copathogens. To our knowledge, ours is the first report of the aetiological role of DEC from the Arabian Gulf region.

Conclusion

This case-control study has shown that DEC are not significantly associated with acute diarrhoea in hospitalised children in Kuwait.

Authors' contributions

MJA, VOR, ASP and GS conceived the study and MJA wrote the paper. RD and AMM participated in clinical aspects of the study and specimen collection. SS performed the laboratory studies. All authors read and approved the final manuscript.

Contributor Information

M John Albert, Email: john@hsc.edu.kw.

Vincent O Rotimi, Email: vincent@hsc.edu.kw.

Rita Dhar, Email: ritapmdhar@gmail.com.

Susan Silpikurian, Email: supikurian@yahoo.com.

Alexander S Pacsa, Email: pacsa@hsc.edu.kw.

A Majid Molla, Email: majid@hsc.edu.kw.

Gyorgy Szucs, Email: gszucs@hsc.edu.kw.

Acknowledgements

This study was supported by Kuwait University grants (numbers MK01/04 and CM01/04). We thank hospital staff for assistance with collection of stool samples. Thomas Cheasty, Health Protection Agency, Laboratory of Enteric Pathogens, Colindale, England, the United Kingdom, helped with the serotyping of E. coli strains.

References

  1. The World Factbook. https://www.cia.gov/library/publications/the-world-factbook/print/ku.html
  2. Feb 2008: international comparison program. http://www.finfacts.com/biz10/globalworldincomepercapita.htm
  3. Sethi SK, Khuffash FA, Al-Nakib W. Microbial etiology of acute gastroenteritis in hospitalized children in Kuwait. Pediatr Infect Dis J. 1989;8:593–597. doi: 10.1097/00006454-198909000-00005. [DOI] [PubMed] [Google Scholar]
  4. Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2:123–140. doi: 10.1038/nrmicro818. [DOI] [PubMed] [Google Scholar]
  5. Robins-Browne RM, Hartland EL. Escherichia coli as a cause of diarrhea. J Gastroenterol Hepatol. 2002;17:467–475. doi: 10.1046/j.1440-1746.2002.02769.x. [DOI] [PubMed] [Google Scholar]
  6. Ramachandran V, Brett K, Hornitzky MA, Dowton M, Bettelheim KA, Walker MJ, Djordjevic SP. Distribution of intimin subtypes among Escherichia coli isolates from ruminant and human sources. J Clin Microbiol. 2003;41:5022–5032. doi: 10.1128/JCM.41.11.5022-5032.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Robins-Browne RM, Bordun A-M, Tauschek M, Bennett-Wood VR, Russell J, Oppedisano F, Lister NA, Bettelheim KA, Fairley CK, Sinclair MI, Hellard ME. Escherichia coli and community-acquired gastroenteritis, Melbourne, Australia. Emerg Infect Dis. 2004;10:1797–1805. doi: 10.3201/eid1010.031086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sethabutr O, Venkatesan M, Yam S, Pang LW, Smoak BL, Sang WK, Echeverria P, Taylor DN, Isenbarger DW. Detection of PCR products of the ipaH gene from Shigella and enteroinvasive Escherichia coli by enzyme-linked immunosorbent assay. Diagn Microbiol Infect Dis. 2000;37:11–16. doi: 10.1016/S0732-8893(00)00122-X. [DOI] [PubMed] [Google Scholar]
  9. Gross RJ, Rowe B. In: The virulence of Escherichia coli: reviews and methods. Sussman M, editor. Academic Press Inc: London; 1985. Serotype of Escherichia coli. [Google Scholar]
  10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: fifteenth informational supplement. Clinical Laboratory Standards Institute, Wayne, PA; 2005. [Google Scholar]
  11. Rotimi VO, Jamal W, Pal T, Sovenned A, Albert MJ. Emergence of CTX-M-15 type extended-spectrum β-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates. J Med Microbiol. 2008;57:881–886. doi: 10.1099/jmm.0.47509-0. [DOI] [PubMed] [Google Scholar]
  12. World Health Organisation. Manual for laboratory investigations of acute enteric infections. World Health Organisation, Geneva; 1987. Programme for control of diarrhoeal diseases (CDD/83.3 Rev 1) p. 27. [Google Scholar]
  13. Levine MM, Edelman R. Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: epidemiology and pathogenesis. Epidemiol Rev. 1984;6:31–51. doi: 10.1093/oxfordjournals.epirev.a036274. [DOI] [PubMed] [Google Scholar]
  14. Rao MR, Abu-Elyazeed R, Savarino SJ, Naficy AB, Wierzba TF, Abdel-Messih I, Shaheen H, Frenck RW Jr, Svennerholm A-M, Clemens JD. High disease burden of diarrhea due to enterotoxigenic Escherichia coli among rural Egyptian infants and young children. J Clin Microbiol. 2003;41:4862–64. doi: 10.1128/JCM.41.10.4862-4864.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Aslani MM, Ahrabi SS, Alikhani YM, Jafari F, Zali RM, Mani M. Molecular detection and antimicrobial resistance of diarrheagenic Escherichia coli strains isolated from diarrheal cases. Saudi Med J. 2008;29:388–392. [PubMed] [Google Scholar]
  16. Al-Gallas N, Bahri O, Bouratbeen A, Ben Haasen A, Ben Aissa R. Etiology of acute diarrhea in children and adults in Tunis, Tunisia, with emphasis on diarrheagenic Escherichia coli: prevalence, phenotyping, and molecular epidemiology. Am J Trop Med Hyg. 2007;77:571–582. [PubMed] [Google Scholar]
  17. Porat N, Levy A, Fraser D, Deckelbaum RJ, Dagan R. Prevalence of intestinal infections caused by diarrheagenic Escherichia coli in Bedouin infants and young children in Southern Israel. Pediatr Infect Dis J. 1998;17:482–488. doi: 10.1097/00006454-199806000-00010. [DOI] [PubMed] [Google Scholar]
  18. Trabulsi LR, Keller R, Gomes TAT. Typical and atypical enteropathogenic Escherichia coli. Emerg Infect Dis. 2002;8:508–513. doi: 10.3201/eid0805.010385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Afset JE, Bergh K, Bevanger L. High prevalence of atypical enteropathogenic Escherichia coli (EPEC) in Norwegian children with diarrhoea. J Med Microbiol. 2003;52:1015–1019. doi: 10.1099/jmm.0.05287-0. [DOI] [PubMed] [Google Scholar]
  20. Bouzari S, Jafari MN, Shokouhi F, Parsi M, Jafari A. Virulence-related DNA sequences and adherence patterns in strains of enteropathogenic Escherichia coli. FEMS Microbiol Lett. 2000;185:89–93. doi: 10.1111/j.1574-6968.2000.tb09045.x. [DOI] [PubMed] [Google Scholar]
  21. Bueris V, Sircili MP, Taddei CR, Santos MF, Franzolin MR, Martinez MB, Ferrer SR, Barreto ML, Trabulsi LR. Detection of diarrheagenic Escherichia coli from children with and without diarrhea in Salvador, Brahia, Brazil. Mem Inst Oswaldo Cruz. 2007;102:839–844. doi: 10.1590/S0074-02762007005000116. [DOI] [PubMed] [Google Scholar]
  22. Gomes TAT, Griffin PM, Ivey C, Trabulsi LR, Ramos SRTS. EPEC infections in Sao Paulo. Rev Microbiol. 1996;27:25–33. [Google Scholar]
  23. Hien BT, Scheutz F, Cam PD, Serichantalergs O, Huong TT, Thu TM, Dalsgaard A. Diarrheagenic Escherichia coli and Shigella strains isolated from children in a hospital case-control study in Hanoi, Vietnam. J Clin Microbiol. 2008;46:996–1004. doi: 10.1128/JCM.01219-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nguyen RN, Taylor LS, Tauschek M, Robins-Browne RM. Atypical enteropathogenic Escherichia coli infection and prolonged diarrhea in children. Emerg Infect Dis. 2006;12:597–603. doi: 10.3201/eid1204.051112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hill SM, Philips AD, Walker-Smith JA. Enteropathogenic Escherichia coli and life-threatening chronic diarrhea. Gut. 1991;32:154–158. doi: 10.1136/gut.32.2.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998;11:142–201. doi: 10.1128/cmr.11.1.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Putnam SD, Riddle MS, Wierzba TF, Pittner BT, Elyazeed RA, El-Gendy A, Rao MR, Clemens JD, Frenck RW. Antimicrobial susceptibility trends among Escherichia coli and Shigella spp. isolated from rural Egyptian paediatric populations with diarrhoea between 1995 and 2000. Clin Microbiol Infect. 2004;10:804–810. doi: 10.1111/j.1469-0691.2004.00927.x. [DOI] [PubMed] [Google Scholar]
  28. Estrada-Garcia T, Cerna JF, Paheco-Gil L, Velazquez RF, Ochoa TJ, Torres J, DuPont HL. Drug-resistant diarrheagenic Escherichia coli, Mexico. Emerg Infect Dis. 2005;11:1306–1308. doi: 10.3201/eid1108.050192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Nguyen TV, Le PV, Le CH, Weintraub A. Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated in children in Hanoi, Vietnam. Antimicrob Agents Chemother. 2005;49:816–819. doi: 10.1128/AAC.49.2.816-819.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Karim A, Poirel L, Nagarajan S, Nordmann P. Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett. 2001;201:237–241. doi: 10.1111/j.1574-6968.2001.tb10762.x. [DOI] [PubMed] [Google Scholar]
  31. Kon M, Kurazono T, Ohshima M, Yamaguchi M, Morita K, Watanabe N, Kanamori M, Matsushita S. Cefotaxime-resistant shiga toxin-producing Escherichia coli O26:H11 isolated from a patient with diarrhea. Kansenshogaku Zasshi. 2005;79:161–168. doi: 10.11150/kansenshogakuzasshi1970.79.161. [DOI] [PubMed] [Google Scholar]
  32. Sonnevend A, Al Dhaheri K, Mag T, Herpay M, Kolodziejek J, Nowotny N, Usmani A, Sheikh FA, Pal T. CTX-M-15-producing multidrug-resistant enteroaggregative Escherichia coli in the United Arab Emirates. Clin Microbiol Infect. 2006;12:582–585. doi: 10.1111/j.1469-0691.2006.01437.x. [DOI] [PubMed] [Google Scholar]
  33. Vignoli R, Varela G, Mota MI, Cordeiro NF, Power P, Ingold E, Gadea P, Sirok A, Schelotto F, Ayala JA, Gutkind G. Enteropathogenic Escherichia coli strains carrying genes encoding the PER-2 and TEM-116 extended -spectrum β-lactamases isolated from children with diarrhea in Uruguay. J Clin Microbiol. 2005;43:2940–2943. doi: 10.1128/JCM.43.6.2940-2943.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Microbiology are provided here courtesy of BMC

RESOURCES